Biogen Inc (NASDAQ:BIIB)
| 301.85 Delayed Data As of Dec 01 |  -3.17 / -1.04%Today’s Change | 187.16 Today|||52-Week Range 311.88 | +25.81% Year-to-Date |
Latest BIIB News | Press Releases
Today’s Trading
| Previous close | 305.02 |
| Today’s open | 305.97 |
| Day’s range | 299.17 - 306.23 |
| Volume | 87,435 |
| Average volume (3 months) | 1,427,476 |
| Market cap | $43.9B |
Data as of 4:00pm ET, 12/01/2022
Growth & Valuation
| Earnings growth (last year) | -58.03% |
| Earnings growth (this year) | -11.15% |
| Earnings growth (next 5 years) | -2.09% |
| Revenue growth (last year) | -15.81% |
| P/E ratio | 15.4 |
| Price/Sales | 3.45 |
| Price/Book | 4.12 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ILMNIllumina Inc | +2.78 | +1.27% |
| ---- | ||
| BMRNBiomarin Pharmaceuti... | +2.07 | +2.05% |
| MRNAModerna Inc | +5.57 | +3.17% |
Data as of 4:00pm ET, 12/01/2022
Financials
| Next reporting date | February 2, 2023 |
| EPS forecast (this quarter) | $3.48 |
| Annual revenue (last year) | $10.4B |
| Annual profit (last year) | $1.6B |
| Net profit margin | 14.96% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
